OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of FoxO Proteins in Cellular Response to Antitumor Agents
Giovanni Luca Beretta, Cristina Corno, Nadia Zaffaroni, et al.
Cancers (2019) Vol. 11, Iss. 1, pp. 90-90
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

Therapeutic strategies targeting FOXO transcription factors
Giampaolo Calissi, Eric W.‐F. Lam, Wolfgang Link
Nature Reviews Drug Discovery (2020) Vol. 20, Iss. 1, pp. 21-38
Closed Access | Times Cited: 247

FOXO transcription factor family in cancer and metastasis
Yannasittha Jiramongkol, Eric W.‐F. Lam
Cancer and Metastasis Reviews (2020) Vol. 39, Iss. 3, pp. 681-709
Open Access | Times Cited: 208

Dual role of Endoplasmic Reticulum Stress-Mediated Unfolded Protein Response Signaling Pathway in Carcinogenesis
Natalia Siwecka, Wioletta Rozpędek‐Kamińska, Dariusz Pytel, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 18, pp. 4354-4354
Open Access | Times Cited: 131

FOXO family isoforms
Bruno Santos, Inês Grenho, Paulo Martel, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 10
Open Access | Times Cited: 33

Cancer Mutations Converge on a Collection of Protein Assemblies to Predict Resistance to Replication Stress
Xiaoyu Zhao, Akshat Singhal, Sungjoon Park, et al.
Cancer Discovery (2024) Vol. 14, Iss. 3, pp. 508-523
Open Access | Times Cited: 12

What sustains the multidrug resistance phenotype beyond ABC efflux transporters? Looking beyond the tip of the iceberg
Teodora Alexa‐Stratulat, Milica Pešić, Ana Čipak Gašparović, et al.
Drug Resistance Updates (2019) Vol. 46, pp. 100643-100643
Closed Access | Times Cited: 67

Targeting the core of neurodegeneration: FoxO, mTOR, and SIRT1
Kenneth Maiese
Neural Regeneration Research (2020) Vol. 16, Iss. 3, pp. 448-448
Open Access | Times Cited: 65

FoxO3 reverses 5-fluorouracil resistance in human colorectal cancer cells by inhibiting the Nrf2/TR1 signaling pathway
Chao Liu, Yan Zhao, Jianing Wang, et al.
Cancer Letters (2019) Vol. 470, pp. 29-42
Closed Access | Times Cited: 59

Therapeutic potential of Scutellaria baicalensis Georgi in lung cancer therapy
Xiang Li, Yue Gao, Shiyu Chen, et al.
Phytomedicine (2021) Vol. 95, pp. 153727-153727
Closed Access | Times Cited: 49

Diffuse Intrinsic Pontine Glioma (DIPG): Breakthrough and Clinical Perspective
Maria Grazia Perrone, Antonio Ruggiero, Antonella Centonze, et al.
Current Medicinal Chemistry (2020) Vol. 28, Iss. 17, pp. 3287-3317
Closed Access | Times Cited: 36

Cdc20 induces the radioresistance of bladder cancer cells by targeting FoxO1 degradation
Lixia Wang, Chuanlai Yang, Man Chu, et al.
Cancer Letters (2020) Vol. 500, pp. 172-181
Closed Access | Times Cited: 35

Role of Forkhead Box O Proteins in Hepatocellular Carcinoma Biology and Progression (Review)
Shaojie Yang, Liwei Pang, Wanlin Dai, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 30

Role of Forkhead Box Protein O1 (FoxO1) in Stroke: A Literature Review
Sichao Guo, Ruchi Mangal, Chaitu Dandu, et al.
Aging and Disease (2022) Vol. 13, Iss. 2, pp. 521-521
Open Access | Times Cited: 20

A novel defined risk signature of endoplasmic reticulum stress-related genes for predicting the prognosis and immune infiltration status of ovarian cancer
Jiahang Mo, Shunyi Ruan, Baicai Yang, et al.
Journal of Zhejiang University SCIENCE B (2023) Vol. 24, Iss. 1, pp. 64-77
Open Access | Times Cited: 12

Methyltransferase Set7/9 as a Multifaceted Regulator of ROS Response
Alexandra Daks, Oleg Shuvalov, Olga Fedorova, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 8, pp. 2304-2318
Open Access | Times Cited: 11

Cognitive Impairment in Multiple Sclerosis
Kenneth Maiese
Bioengineering (2023) Vol. 10, Iss. 7, pp. 871-871
Open Access | Times Cited: 11

EWS/FLI1 Characterization, Activation, Repression, Target Genes and Therapeutic Opportunities in Ewing Sarcoma
Muhammad Yasir, Jin‐Young Park, Wanjoo Chun
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15173-15173
Open Access | Times Cited: 11

Fraxetin attenuates DNA damage and inflammation in cisplatin-induced nephrotoxicity via FoxO1 activation
Ziwei Yuan, Seung-Yoon Yu, Dongyan Su, et al.
International Immunopharmacology (2025) Vol. 147, pp. 114010-114010
Closed Access

Transcriptome analysis and molecular docking reveal the activation of FOXO4, TNFSF15 and CASP9 in HeLa cells treated with DCM fraction from Clinacanthus nutans ( C. nutans )
Kristine Sandra Pey Adum, Nor Hasyimah Haron, Zaleha Md Toha, et al.
Journal of Asian Natural Products Research (2025), pp. 1-10
Closed Access

Mechanisms of tRNA-derived fragments and tRNA halves in cancer treatment resistance
Yue Zhang, Huizhu Qian, Jing He, et al.
Biomarker Research (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 29

Calorie Restriction-Regulated Molecular Pathways and Its Impact on Various Age Groups: An Overview
Anuradha Rachakatla, Rajender Rao Kalashikam
DNA and Cell Biology (2022) Vol. 41, Iss. 5, pp. 459-468
Closed Access | Times Cited: 17

Baicalin suppress the development of polycystic ovary syndrome via regulating the miR-874-3p/FOXO3 and miR-144/FOXO1 axis
Xiaoyuan Xu, Xiaohua Xu, Xiaoshuang Wang, et al.
Pharmaceutical Biology (2023) Vol. 61, Iss. 1, pp. 878-885
Open Access | Times Cited: 10

Inhibition of autophagy by YC-1 promotes gefitinib induced apoptosis by targeting FOXO1 in gefitinib-resistant NSCLC cells
Hui Hu, Xiaowei Zhang, Li Lin, et al.
European Journal of Pharmacology (2021) Vol. 908, pp. 174346-174346
Closed Access | Times Cited: 21

Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer
Jharna Datta, Natalie Willingham, Jasmine M. Manouchehri, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 15

Page 1 - Next Page

Scroll to top